Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 12, Pages 7164-7170
Publisher
American Society for Microbiology
Online
2014-09-16
DOI
10.1128/aac.03258-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients
- (2013) Erlina Burhan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetics of Rifampin in Peruvian Tuberculosis Patients with and without Comorbid Diabetes or HIV
- (2012) Ana Requena-Méndez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Updated Systematic Review and Meta-analysis on the Treatment of Active Tuberculosis in Patients With HIV Infection
- (2012) F. Ahmad Khan et al. CLINICAL INFECTIOUS DISEASES
- Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis
- (2012) Emma Rey-Jurado et al. TUBERCULOSIS
- The impact of diabetes on tuberculosis treatment outcomes: A systematic review
- (2011) Meghan A Baker et al. BMC Medicine
- The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis
- (2011) A.D. Harries et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The HIV-associated tuberculosis epidemic—when will we act?
- (2010) Anthony D Harries et al. LANCET
- Treatment of tuberculosis and optimal dosing schedules
- (2010) K. C. Chang et al. THORAX
- Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes
- (2009) R. Ruslami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history
- (2008) Audrey Sabbagh et al. BMC GENETICS
- Long term efficacy of DOTS regimens for tuberculosis: systematic review
- (2008) Helen S Cox et al. BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started